| Title: | Genetics of ankylosing spondylitis |
| Lead Institution: | King's College London |
| Principal investigator: | Professor Matthew Brown |
Application 21024
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
1. To identify genes involved in ankylosing spondylitis 2. To test genetic risk prediction for ankylosing spondylitis 3. To test whether HLA-B27 influences the risk of ischaemic heart disease and mortality. The study aims to improve treatment and potentially prevention of AS both by identifying novel therapeutic targets, and developing methods to improve early diagnosis of the disease, which currently has a mean 10 year diagnostic delay. Ankylosing spondylitis cases will be identified from the registry. The accuracy of the diagnosis will be tested by investigating the prevalence of HLA-B27 in cases, which should be >80%. If that threshold is achieved then case genotypes will be compared with controls by standard GWAS approaches. Genetic risk scores developed using a 25000 case GWAS we are currently completing will be tested for their positive and negative predictive value in the UK Biobank cohort. Full cohort1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 9611 | HLA-B27, axial spondyloarthritis and survival | Zhixiu Li (+8) | 2023 | Annals of the Rheumatic Diseases |
Enabling scientific discoveries that improve human health